Updates and insights in the diagnosis and management of DRESS syndrome
EM Schunkert, SJ Divito - Current dermatology reports, 2021 - Springer
Abstract Purpose of Review To provide updates on recent advances in the diagnosis and
management of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome …
management of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome …
Drug reaction with eosinophilia and systemic symptoms (DRESS): focus on the pathophysiological and diagnostic role of viruses
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a heterogeneous,
multiorgan and potentially life-threatening drug-hypersensitivity reaction (DHR) that occurs …
multiorgan and potentially life-threatening drug-hypersensitivity reaction (DHR) that occurs …
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and …
BM Wei, LP Fox, BH Kaffenberger, AM Korman… - Journal of the American …, 2023 - Elsevier
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …
Management and treatment outcome of DRESS patients in Europe: an international multicentre retrospective study of 141 cases
K Kridin, MC Brüggen, S Walsh… - Journal of the …, 2023 - Wiley Online Library
Background Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but
potentially fatal drug hypersensitivity reaction. Objective To explore treatment approaches …
potentially fatal drug hypersensitivity reaction. Objective To explore treatment approaches …
Immunopathogenic insights on preferential human herpesvirus-6 reactivation in drug rash with eosinophilia and systemic symptoms: a scoping review
H Zhu, V Ren - Journal of Cutaneous Medicine and Surgery, 2023 - journals.sagepub.com
Introduction Human herpesvirus-6 (HHV-6) is a ubiquitous lymphotropic betaherpesvirus
that can reactivate in drug rash with eosinophilia and systemic symptoms (DRESS). Despite …
that can reactivate in drug rash with eosinophilia and systemic symptoms (DRESS). Despite …
Morphologic Spectrum of Lymphadenopathy in Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Case Series With Literature Review
HC Chen, RC Wang, HP Tsai… - … of Pathology & …, 2022 - meridian.allenpress.com
Context.—Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and
systemic symptoms (DRESS) is a drug-induced, adverse T-cell–mediated hypersensitivity …
systemic symptoms (DRESS) is a drug-induced, adverse T-cell–mediated hypersensitivity …
Cutaneous lesions in a solid organ transplant recipient: A diagnostic dilemma
J Ferguson, C Cervera, B Kaffenberger… - Transplant Infectious …, 2022 - Wiley Online Library
Cutaneous lesions in a solid organ transplant recipient: A diagnostic dilemma - Ferguson - 2022
- Transplant Infectious Disease - Wiley Online Library Skip to Article Content Skip to Article …
- Transplant Infectious Disease - Wiley Online Library Skip to Article Content Skip to Article …
Clinical features of drug reaction with eosinophilia and systemic symptoms: A retrospective study in a reference centre of dermatology in Madagascar
FA Sendrasoa, BC Imbelona… - JEADV Clinical …, 2024 - Wiley Online Library
Background Drug reaction with eosinophilia and systemic symptoms (DRESS) is drug‐
induced hypersensitivity reaction that can have fatal complications. Three sets of diagnostic …
induced hypersensitivity reaction that can have fatal complications. Three sets of diagnostic …
Validation of Rash and Nonspecific Eruption Diagnoses Using ICD-9 and ICD-10 Codes
M Goldenberg, M Amigo, SG Krishna… - Academic …, 2023 - ojs.library.osu.edu
Despite being common cutaneous findings in the hospital setting, cutaneous drug eruptions
have not been thoroughly validated for administrative claims data. The purpose of this study …
have not been thoroughly validated for administrative claims data. The purpose of this study …